Mariner
CRDF icon

Mariner’s Cardiff Oncology CRDF Stock Holding History

Mariner’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.4K Buy
+14,451
New +$29.7K ﹤0.01% 3483
2025
Q3 		– Sell
-18,149
Closed -$57.2K – 3602
2025
Q2 		$57.2K Sell
18,149
-164
-0.9% -$500 ﹤0.01% 3329
2025
Q1 		$57.5K Buy
18,313
+4,266
+30% +$16.9K ﹤0.01% 3293
2024
Q4 		$61K Buy
+14,047
New +$43.9K ﹤0.01% 3267

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Mariner's CRDF Position: Q1 2026 in Review

Mariner opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 14,451 shares worth $23.4K. The stake represents ﹤0.01% of the portfolio and ranks #3483 among its holdings. This is a return to the name: Mariner previously reported a position in CRDF as recently as Q2 2025.

Mariner first reported a position in CRDF in Q4 2024 and has held it in 4 quarters since. The position peaked at $61K in Q4 2024. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Mariner held 14,451 shares of Cardiff Oncology worth $23.4K as of Q1 2026.
  • Cardiff Oncology was a new Mariner position in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3483 holding.
  • Mariner first reported a position in Cardiff Oncology in Q4 2024 and has held it in 4 quarters since.
  • Mariner's Cardiff Oncology position peaked at $61K in Q4 2024.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.